Small Molecule Antivirals

Our small molecule discovery program is focused on developing agents that target receptors known to initiate direct anti-viral activity while bypassing the many upstream pathways associated with interferon therapy. The objective of this program is to create novel small molecules that have broad spectrum anti-viral activity and are not associated with interferon related toxicity.